Merck

Merck is a biopharmaceutical company dedicated to discovering, developing, and providing innovative medicines and vaccines. With a focus on various diseases, including cancer, infectious diseases, and vaccines, Merck operates globally, with approximately 47% of its sales generated from the US human health segment.

Robert M. Davis

Executive Vice President and CFO

Kenneth Frazier

CEO and Chairman of the Board

Maxwell Kahn

Managing Director

Dave Stevenson

Managing Director

Prem Tumkosit

Managing Director

Joe Volpe

Managing Director and Founding Partner

Past deals in South Dakota

SAb Biotherapeutics

Series B in 2020
SAB Biotherapeutics is a clinical-stage biopharmaceutical company established in 2014, headquartered in Sioux Falls, South Dakota with additional offices in Cambridge, Massachusetts. The company specializes in developing immunotherapies using its proprietary DiversitAb platform, which employs transchromosomic cattle to produce large quantities of targeted human polyclonal antibodies without relying on human plasma or serum. SAB's pipeline includes therapies for conditions such as Type 1 diabetes (SAB-142), seasonal influenza (SAB-176), and Middle East Respiratory Syndrome Coronavirus (MERS-CoV, SAB-301).
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.